Development of the 7-Item Binge-Eating Disorder Screener (BEDS-7)

Herman, Barry K.; Deal, Linda S.; DiBenedetti, Dana; Nelson, Lauren; Fehnel, Sheri; Brown, T. Michelle

doi:10.4088/pcc.15m01896

Cited by 58 publications

(63 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A screening instrument, based on the DSM-5 criteria, is available. 24,25 Although physical comorbidities including obesity and metabolic syndrome are common, and may prompt a discussion of eating behaviors, not all persons with BED are obese. Because BED is commonly associated with other psychiatric disorders that bring them to treatment, such as anxiety, depression, impulse control disorders, and substance use, routine assessment of eating behaviors is advisable because persons with prominent coexisting psychiatric conditions, and as yet undiagnosed BED, may not bring up eating issues on their own.…”

Section: Review Of the Dsm-5 Diagnostic Criteria For Bedmentioning

confidence: 99%

“…52 As noted, a screening instrument is available. 24,25 Called the Binge Eating Disorder Screener-7 (BEDS-7), it was developed based in part on the DSM-5 diagnostic criteria and is intended to be completed by the patient. The first question is "During the last 3 months, did you have any episodes of excessive overeating (i.e., eating significantly more than what most people would eat in a similar period of time)?"…”

Section: Recognizing and Diagnosing Binge Eating Disordermentioning

confidence: 99%

See 1 more Smart Citation

Binge eating disorder revisited: what’s new, what’s different, what’s next

Citrome

2019

CNS Spectr.

View full text Add to dashboard Cite

Binge eating disorder (BED) is the most common type of eating disorder. According to the most recent data available, the estimated lifetime prevalence of BED among US adults in the general population is 0.85% (men 0.42% and women 1.25%). Among psychiatric treatment populations, prevalence is several-fold higher. Although many people with BED are obese (BMI ≥ 30 kg/m2), roughly half are not. In the DSM-5, BED is defined by recurrent episodes of binge eating (eating in a discrete period of time, an amount of food larger than most people would eat in a similar amount of time under similar circumstances and a sense of lack of control over eating during the episode), occurring on average at least once a week for 3 months, and associated with marked distress. BED often goes unrecognized and thus untreated; in one study, 344 of 22,387 (1.5%) survey respondents met DSM-5 criteria for BED, but only 11 out of the 344 had ever been diagnosed with BED by a health-care provider. Psychiatric comorbidities are very common, with most adults with BED also experiencing anxiety disorders, mood disorders, impulse control disorders, or substance use disorders, suggesting that clinicians have patients in their practice with unrecognized BED. Multiple neurobiological explanations have been suggested for BED, including dysregulation in reward center and impulse control circuitry. Additionally, there is interplay between genetic influences and environmental stressors. Psychological treatments such as cognitive behavioral interventions have been recommended as first line and are supported by meta-analytic reviews; however, access to such treatments may be limited because of local availability and/or cost, and these treatments generally lead to little to no weight loss, although successfully eliminating binge eating can protect against future weight gain. Routine medication treatments for anxiety and depression do not necessarily ameliorate the symptoms of BED, but there are approved and emerging medication options, lisdexamfetamine and dasotraline, respectively, that specifically address the core drivers behind binge eating, namely obsessive thoughts and compulsive behaviors regarding food, resulting in marked decreases in binge eating behaviors as well as weight loss.

show abstract

Section: Review Of the Dsm-5 Diagnostic Criteria For Bedmentioning

confidence: 99%

Section: Recognizing and Diagnosing Binge Eating Disordermentioning

confidence: 99%

Binge eating disorder revisited: what’s new, what’s different, what’s next

Citrome

2019

CNS Spectr.

View full text Add to dashboard Cite

show abstract

“…A screening instrument, the Binge Eating Disorder Screener-7 (BEDS-7), has been developed based in part on the DSM-5 diagnostic criteria. 34,35 The BEDS-7 is completed by the patient and is intended for screening use only. The first question is, "During the last 3 months, did you have any episodes of excessive overeating (ie, eating significantly more than what most people would eat in a similar period of time)?"…”

Section: Recognizing and Diagnosing Binge Eating Disordermentioning

confidence: 99%

“…A screening instrument, the Binge Eating Disorder Screener-7 (BEDS-7), has been developed based in part on the DSM-5 diagnostic criteria 34 , 35 . The BEDS-7 is completed by the patient and is intended for screening use only.…”

Section: Recognizing and Diagnosing Binge Eating Disordermentioning

confidence: 99%

A primer on binge eating disorder diagnosis and management

Citrome

2015

CNS Spectr.

View full text Add to dashboard Cite

Binge eating disorder (BED) is the most common eating disorder, with an estimated lifetime prevalence of 2.6% among U.S. adults, yet often goes unrecognized. In the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), BED is defined by recurrent episodes of binge eating (eating in a discrete period of time an amount of food larger than most people would eat in a similar amount of time under similar circumstances and a sense of lack of control over eating during the episode), occurring on average at least once a week for 3 months, and associated with marked distress. It can affect both men and women, regardless if they are at normal weight, overweight, or obese, and regardless of their ethnic or racial group. Psychiatric comorbidities are very common, with 79% of adults with BED also experiencing anxiety disorders, mood disorders, impulse control disorders, or substance use disorders; almost 50% of persons with BED have ≥ 3 psychiatric comorbidities. Multiple neurobiological explanations have been proffered for BED, including dysregulation in reward center and impulse control circuitry, with potentially related disturbances in dopamine neurotransmission and endogenous μ-opioid signaling. Additionally, there is interplay between genetic influences and environmental stressors. Psychological treatments such as cognitive behavioral interventions have been recommended as first line and are supported by meta-analytic reviews. Unfortunately, routine medication treatments for anxiety and depression do not necessarily ameliorate the symptoms of BED; however, at present, there is one approved agent for the treatment of moderate to severe BED-lisdexamfetamine, a stimulant that was originally approved for the treatment of attention deficit hyperactivity disorder.

show abstract

“…I encourage clinicians to include one additional sentence in their standard line of questions regarding appetite, and that would be ‘have you ever eaten more than you intended?’ followed up with ‘did you feel like it wasn't easy to stop?’ This would go a long way in opening the door to a discussion of a topic that has been a source of concern, embarrassment, and guilt for that individual. Handy screening instruments are also available . If BED is ultimately diagnosed, effective treatments are available , and will likely increase your chance of success when managing all those comorbidities that brought your patient to your attention in the first place.…”

mentioning

confidence: 99%